Aldose Reductase (AKR1B1) Antibody (HRP)

Este producto es parte de AKR1B - Aldo-keto reductase family 1 member B
Aldose Reductase (AKR1B1) Antibody (HRP)
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Aldose Reductase (AKR1B1) Antibody (HRP)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx314044
Tested Applications
ELISA

Description

AKR1B1 Antibody (HRP) is a Rabbit Polyclonal against AKR1B1 conjugated to HRP.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Aldose Reductase (AKR1B1)
Immunogen: Recombinant human Aldose reductase protein (114-230AA).
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
HRP
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P15121
Gene ID
231
NCBI Accession
NP_001619.1
OMIM
103880
Alias
AKR1B1,ADR ALDR1,ALR2,AR
Background
Antibody anti-AKR1B1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

AKR1B1, also known as aldose reductase, is a key enzyme in the polyol pathway that converts glucose to sorbitol under hyperglycemic conditions. It has a significant role in the pathogenesis of diabetic complications, such as neuropathy, nephropathy, and retinopathy, as sorbitol accumulation induces osmotic stress and oxidative damage. AKR1B1 also metabolizes reactive aldehydes, including lipid peroxidation products like 4-hydroxynonenal (4-HNE), contributing to cellular detoxification under oxidative stress. Its overactivation under diabetic and inflammatory conditions exacerbates oxidative stress and inflammatory signaling pathways. AKR1B1 inhibitors have been developed as potential therapeutic agents for managing diabetic complications. Beyond diabetes, AKR1B1 is involved in steroid metabolism and the detoxification of xenobiotics. It has also been implicated in cancer progression, as its expression is upregulated in some tumors, promoting proliferation and chemoresistance by reducing reactive aldehydes and maintaining cellular redox balance.

Productos relacionados

abx001414

Aldose Reductase (AKR1B1) Antibody

AKR1B1 Antibody is a Rabbit Polyclonal antibody against AKR1B1. This gene encodes a member of the aldo/keto reductase su…

Ver producto
abx014171

Aldose Reductase (AKR1B1) Antibody

Rabbit polyclonal antibody against AKR1B1 protein. Immunogen region is C-terminal.…

Ver producto
abx018217

Aldose Reductase (AKR1B1) Antibody

AR Antibody is a Mouse Monoclonal antibody against AR.…

Ver producto